共 50 条
Primary clear cell adenocarcinoma of prostate: A diagnostic challenge
被引:2
|作者:
Chang, Che-Wei
[1
,2
,4
]
Yin, Hsin-Ling
[3
]
Li, Ching-Chia
[2
,4
,5
]
机构:
[1] Kaohsiung Municipal Siaogang Hosp, Dept Urol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Coll Med, Dept Grad Inst Clin Med, Kaohsiung, Taiwan
关键词:
Clear cell adenocarcinoma;
immunotherapy;
prostate;
URETHRA;
CARCINOMA;
D O I:
10.4103/UA.UA_187_20
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Clear cell adenocarcinoma (CCA) rarely occurs in men, not to mention in prostate. We reported a 44-year-old male patient who suffered from recurrent dysuria and frequency for 6 months. Transurethral resection of the prostate was performed to relieve bladder outlet obstruction. However, CCA of the prostate was confirmed through pathological examination. A thorough checkup was performed to distinguish it from metastatic clear cell carcinoma from other primary origins. Currently, no consensus for the treatment of CCA of the prostate has been reached. After discussing with the patient, he decided to receive immunotherapy with pembrolizumab. Herein, we reported this rare case of CCA in the prostate.
引用
收藏
页码:434 / 437
页数:4
相关论文